Pharmaceutical Executive
Active Care Network and biotech partners aim to increase patient compliance.
Pharmaceutical Executive-06-06-2007
Pharmaceutical Executive
Drug makers find it hard to recoup development costs, report finds.
Pharmaceutical Executive
Restasis goes against the grain of Rx-to-OTC switching.
Advertisement
Advertisement
Trending on PharmExec
1
Roundup: FDA Approves Novo Nordisk's Rybelsus and Roche’s Gazyva/Gazyvaro
2
Merck Planning $70 Billion Investment for US Expansion
3
Amazon and WeightWatchers Partner for DTC Weight Loss Medication Offerings
4
FDA Approves Tezspire as First Biologic Targeting TSLP for Chronic Rhinosinusitis With Nasal Polyps
5
